Procalcitonin As A Diagnostic And Prognostic Marker In Community Acquired Pneumonia

被引：0
|
作者：
Bappanad, D. [1 ]
Moser, B. [2 ]
Woods, C. [1 ]
Cairns, C. B. [3 ]
Kraft, M. [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Duke Univ, Sch Med, Durham, NC USA
[3] Univ N Carolina, Chapel Hill, NC USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5972
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Procalcitonin in children admitted to hospital with community acquired pneumonia
    Moulin, F
    Raymond, J
    Lorrot, M
    Marc, E
    Coste, J
    Iniguez, JL
    Kalifa, G
    Bohuon, C
    Gendrel, D
    ARCHIVES OF DISEASE IN CHILDHOOD, 2001, 84 (04) : 332 - 336
  • [22] Procalcitonin for detecting community-acquired bacterial pneumonia
    Gusmaiyanto, Devi
    Yani, Finny Fitry
    Efrida
    Machmud, Rizanda
    PAEDIATRICA INDONESIANA, 2015, 55 (02) : 65 - 69
  • [23] Is Neutrophil To Lymphocyte Ratio Useful Prognostic Marker For Patients With Community Acquired Pneumonia
    Son, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [24] Soluble ST2 as a prognostic marker in community-acquired pneumonia
    Watanabe, Masato
    Takizawa, Hajime
    Tamura, Masaki
    Nakajima, Akira
    Kurai, Daisuke
    Ishii, Haruyuki
    Takata, Saori
    Nakamoto, Keitaro
    Sohara, Erei
    Honda, Koujirou
    Nakamura, Masuo
    Inui, Toshiya
    Wada, Hiroo
    Goto, Hajime
    JOURNAL OF INFECTION, 2015, 70 (05) : 474 - 482
  • [25] Soluble St2 As A Prognostic Marker Of Community-Acquired Pneumonia
    Watanabe, M.
    Takizawa, H.
    Tamura, M.
    Nakajima, A.
    Honda, K.
    Nakamura, M.
    Wada, H.
    Ishii, H.
    Goto, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [26] Etiological and prognostic values of procalcitonin in hospital-acquired pneumonia
    Abu Elkhashab, Ahmed E.
    Swelem, Rania S.
    Abd Alla, Alaa El Din A.
    Hattata, Eman A.
    Atta, Mohamed S.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2014, 63 (01): : 201 - 206
  • [27] Procalcitonin in inflammatory bowel disease: A diagnostic or prognostic marker
    Pournaghi, Seyed-Javad
    Jamialahmadi, Hamid
    Pazhohan-Nezhad, Hadis
    Moghbeli, Meysam
    Saburi, Amin
    Eghbal, Fatemeh
    Nakhlband, Ailar
    Saburi, Ehsan
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 262
  • [28] Procalcitonin as an Early Marker of the Need for Invasive Respiratory or Vasopressor Support in Adults With Community-Acquired Pneumonia
    Self, Wesley H.
    Grijalva, Carlos G.
    Williams, Derek J.
    Woodworth, Alison
    Balk, Robert A.
    Fakhran, Sherene
    Zhu, Yuwei
    Courtney, D. Mark
    Chappell, James
    Anderson, Evan J.
    Qi, Chao
    Waterer, Grant W.
    Trabue, Christopher
    Bramley, Anna M.
    Jain, Seema
    Edwards, Kathryn M.
    Wunderink, Richard G.
    CHEST, 2016, 150 (04) : 819 - 828
  • [29] Community-Acquired Pneumonia Diagnostic vs Prognostic Significance of the Platelet Count
    Cunha, Burke A.
    Hage, Jean E.
    CHEST, 2011, 139 (05) : 1255 - 1256
  • [30] Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia
    Mueller, Beat
    Harbarth, Stephan
    Stolz, Daiana
    Bingisser, Roland
    Mueller, Christian
    Leuppi, Joerg
    Nusbaumer, Charly
    Tamm, Michael
    Christ-Crain, Mirjam
    BMC INFECTIOUS DISEASES, 2007, 7 (1)
12345